FDA Warning Letter — N.Y.S. Psychiatric Institute IRB

Case 670989 — FEI 2431841

The FDA took a Warning Letter action against N.Y.S. Psychiatric Institute IRB on Mar 21, 2024 (New York, NY). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
N.Y.S. Psychiatric Institute IRB
Date
Mar 21, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
New York, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.